Ingen Technologies Inc.’s (OTC:IGNT) former CEO, Scott Sand, is headed to the slammer for his role in a plot involving the illegal manipulation of his company’s stock price.
The Yucaipa, Calif.-based medical device manufacturer named Tom Neavitt interim CEO to replace Sand and said current COO Gary Tilden will take over its day-to-day operations.
A look at the critical business issues companies need to address when developing medical devices.
MassDevice and Clinquest, a healthcare product development services firm, are pleased to offer a free copy of the MassDevice “Eye on the FDA” report for 2009 to all of our readers for the month of August.
The “Eye on the FDA” report is the flagship intelligence report of MassDevice, analyzing trends in the 510(K) premarket approval process.
Users wishing to take advantage of this offer should visit the “Eye on the FDA” report page and use the code “clinquest” during checkout.
About the sponsor
MassDevice Network
@MassDevice
LinkedIn
YouTube